摘要 |
The invention relates to compounds of formula I or pharmaceutically acceptable salts or solvates thereof: where Ar<SUB>1</SUB>, Ar<SUB>2</SUB>, Hy, L, R<SUB>1</SUB>, m and n are as defined in the description. The invention also includes pharmaceutical compositions and uses thereof, processes for making the compounds, as well as methods for the medical treatment of mGluR5-mediated disorders. |